Biochemistry and physiology of blood coagulation

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 165-174

  Mann, Kenneth G ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b C 401 Given Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

BIOCHEMISTRY; BLOOD CLOTTING; CONFERENCE PAPER; HEMODYNAMICS; MATHEMATICAL MODEL; PHYSIOLOGY; PRIORITY JOURNAL;

EID: 0032697618     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615780     Document Type: Conference Paper

References (54)

1. Schmidt A. Neue Untersuchungen ueber die Fasserstoffesgerinnung. Pflueger's Arch.f.ges.Physiol. 1872;6:413-538.
2. Morawitz P. Die Chemie der Blutgerrinnung. Ergebn Physiol. 1905;4:307-423.
3. Patek AJ, Taylor FHL. Hemophilia II: some properties of a substance obtained from normal plasma effective in accelerating the clotting of hemophilic blood. J Clin Invest. 1937;113-124.
4. Brinkhous KM. Clotting defect in hemophilia: deficiency in a plasma factor required for platelet utilization. Proc Soc Exp Biol Med. 1947;66:117-120.
5. Aggeler PM, White SG, Glendenning MB. Plasma thromboplastin component (PTC) deficiency: a new disease resembling hemophilia. Proc Soc Exp Bio Med. 1952;79:692-694.
6. Schulman ISCH: Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood. 1952;7:794-807.
7. Biggs R, Douglas AS, MacFarlane RG, et al. Christmas disease: a condition previously mistaken for hemophilia. Br Med J. 1952;2:1378-1382.
8. Bachmann F, Duckert F, Koller K. The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh. 1999;2:24-38.
9. Alexander B, Goldstein RA, Landweher G, et al. Congenital SPCA deficiency: a hither to unrecognized coagulation defect with hemorrhage rectified by serm and serum fractions. J Clin Invest. 1951;30:596-608.
10. Soulier JP, Wartell O, Menache D. Caracteres differentiels des facteurs hageman et P.T.A.; role due contact dans la phase initiate de la coagulation. Rev Franc Etudes Clin Biol. 1958;3:363
11. Botti RE, Ratnoff OD. The clot-promoting effect of soaps of long-chain saturated fatty acids. J.Clin.Invest. 1963;42:1569-1577.
12. Owren PA. Parahaemophilia. Haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet. 1947;1:446-448.
13. Wright IS. The nomenclature of blood clotting factors. Thromb Diath Haemost. 1962;7:381-388.
14. Warner ED, Brinkhous KM, Smith HP. A quantitative study of blood clotting. Am J Physiol. 1936;114:667-675.
15. Quick AJ. On the Constitution of Prothrombin. Am J Physiol. 1999;140:212-220.
16. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests: a presumptive test for hemophilia and a single one-stage anti-hemophilic factor assay procedure. J Lab Clin Med. 1953;41:7637-7647.
17. Ratnoff OD, Colpy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955;34:602-613.
18. Jacobsen SFM. Some data on two purified kininogens from human plasma. Br.J.Pharmacol. 1967;29:25
19. Mandle RJr, Coleman RW, Kaplan AP. Identification of prekallikrein and high molecular weight kininogen complex in plasma. Proc Natl Acad Sci USA. 1976;F3:4179-4183.
20. Duckert F, Jung SH, Schmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1961;5:179-186.
21. Howell WH. The role of antithrombin and thromboplastin (thromboplastic substance) in the coagulation of blood. Am J Physiol. 1911;29:187-209.
22. Broze GJ, Jr., Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci USA. 1987;84:1886-1890.
23. Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modification of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA. 1974;71:2730-2733.
24. Kisiel W. Human plasma protein C. Isolation, characterization and mechanism of activation by alpha-thrombin. J Clin Invest. 1979;64:761-769.
25. DiScipio RG, Davie EW. Characterization of protein S, a gamma-carboxy-glutamic acid containing protein from bovine and human plasma. Biochem. 1979;18:899-904.
26. Broze GJ, Miletich J. Human Protein Z. J Clin Invest. 1984;73:933.
27. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin catalyzed activation of protein C. Proc Natl Acad Sci USA. 1981;78:2249-2252.
28. MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature. 1964;202:498-499.
29. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science. 1964;145:1310-1312.
30. Osterud B, Rapaport SI. Activation of Factor IX by the reaction product of tissue Factor and Factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci. 1977;74:5260-5260.
31. Gailani D, Broze GJ, Jr.. Factor XI activation in a revised model of blood coagulation. Science. 1991;253:909-912.
32. Ware AG, Seegers WH. Two Stage Procedure for the Quantitative Determination of Prothrombin Concentration. Am J Clin Path. 1949;19:471-482.
33. Seegers WH. Activation of Purified Prothrombin. Proc Soc Exptl Biol Med. 1949;72:677-680.
34. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood and cell populations. J Biol Chem. 1985;260:2119-2124.
35. Nesheim ME, Pittman DD, Wang JH, Slonosky D, Giles AR, Kaufman RJ. The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem. 1988;263:16467-16470.
36. Weiss HJ, Turitto VT, Baumgartner HR. The role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium:Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest. 1986;78:1072
37. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr.. Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623.
38. Mann K, Nesheim M, Church W, Haley P, Krishnaswamy S. Surface dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76:1-16.
39. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81:734-744.
40. Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem. 1992;267:4834-4843.
41. Broze GJ, Jr., Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990;29:7539-7546.
42. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989;264:4743-4746.
43. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994;269:31869-31880.
44. Fay PJ, Smudzin TM. Characterization of the Interaction of the A2 Subunit and AI/A3-C1-C2 Dimer in Human Factor VIII. J Biol Chem. 1992;267:13246-13250.
45. Rosenberg RD, Damus PS. The Purification and Action of Human Antithrombin-Heparin Cofactor. J Biol Chem. 1973;248:6490-6505.
46. Marcum JA, Rosenberg RD. Anticoagulantly active heparinlike molecules from vascular tissue. Biochemistry. 1984;23:1730-1730.
47. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin: 1. an empirical study. J Biol Chem. 1994;269(37):23357-23366.
48. van 't Veer C, Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation: synergistic effect in combination with tissue factor pathway inhibitor. J Biol Chem. 1997;272:7983-7994.
49. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor II. J Biol Chem. 1997;272:4367-4377.
50. Leiden. J Biol Chem. 1997;272:20721-20729.
51. Jones KC, Mann KG. A model for the tissue factor pathway to thrombin: 2. a mathematical simulation. J Biol Chem. 1994;269(37):23367-23373.
52. Shafi T, Jeha JM, Black L, Al Douri M. Severe acquired haemophilia A treated with recombinant factor VIIa. Br J Haematol. 1997;98:910-912.
53. Rand MD, Lock JB, van 't Veer C, et al. Blood clotting in minimally altered whole blood. Blood. 1997;88:3432-3445.
54. Cawthern KM, van 't Veer C, Locke JB, DiLorenzo ME, Branda RF, Mann KG: Blood Coagulation in Hemophilia A and Hemophilia C. Blood. 1998;91:4581-4592